Bnp Paribas Arbitrage, Snc »

Perspective Therapeutics shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2024-06-30 $34k 3.4k 9.97

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
Amazon.com Equity (AMZN)
Meta Platforms Equity (META)
iShares Russell 2000 ETF Fund (IWM)
Tesla Equity (TSLA)
Visa Equity (V)
Alphabet Equity (GOOGL)
Broadcom Equity (AVGO)
Alphabet Equity (GOOG)
SPDR S&P 500 ETF Trust Fund (SPY)
Costco Wholesale Corp Equity (COST)
Exxon Mobil Corp Equity (XOM)
Industrial Select Sector SPDR Fund Fund (XLI)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management

View all funds holding Perspective Therapeutics